
Matthew Yeung
Examiner (ID: 2724, Phone: (571)272-4115 , Office: P/2694 )
| Most Active Art Unit | 2694 |
| Art Unit(s) | 2629, 4125, 2694, 2625 |
| Total Applications | 611 |
| Issued Applications | 443 |
| Pending Applications | 55 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19333659
[patent_doc_number] => 20240248089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => METHOD AND DEVICE FOR DETECTING SIGLEC12
[patent_app_type] => utility
[patent_app_number] => 18/629145
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629145
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629145 | METHOD AND DEVICE FOR DETECTING SIGLEC12 | Apr 7, 2024 | Pending |
Array
(
[id] => 19897876
[patent_doc_number] => 12275782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
[patent_app_type] => utility
[patent_app_number] => 18/621418
[patent_app_country] => US
[patent_app_date] => 2024-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13284
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621418
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/621418 | Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells | Mar 28, 2024 | Issued |
Array
(
[id] => 19173775
[patent_doc_number] => 20240159749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS (PBC) USING NOVEL AUTOANTIGENS
[patent_app_type] => utility
[patent_app_number] => 18/522114
[patent_app_country] => US
[patent_app_date] => 2023-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18522114
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/522114 | METHOD FOR DIAGNOSING PRIMARY BILIARY CIRRHOSIS (PBC) USING NOVEL AUTOANTIGENS | Nov 27, 2023 | Pending |
Array
(
[id] => 18863307
[patent_doc_number] => 20230417743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ANTIBODY-LINKED IMMUNO-SEDIMENTATION AGENT AND METHOD OF ISOLATING A TARGET FROM A SAMPLE USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/241668
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18241668
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/241668 | ANTIBODY-LINKED IMMUNO-SEDIMENTATION AGENT AND METHOD OF ISOLATING A TARGET FROM A SAMPLE USING SAME | Aug 31, 2023 | Pending |
Array
(
[id] => 18846116
[patent_doc_number] => 20230408520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => ARTERIOSCLEROSIS AND CANCER DETECTION METHOD USING DEOXYHYPUSINE SYNTHASE GENE AS INDICATOR
[patent_app_type] => utility
[patent_app_number] => 18/459107
[patent_app_country] => US
[patent_app_date] => 2023-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18459107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/459107 | ARTERIOSCLEROSIS AND CANCER DETECTION METHOD USING DEOXYHYPUSINE SYNTHASE GENE AS INDICATOR | Aug 30, 2023 | Pending |
Array
(
[id] => 18727100
[patent_doc_number] => 20230341381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples
[patent_app_type] => utility
[patent_app_number] => 18/345170
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345170 | Methods and reagents for determining immunoglobulin gamma (IgG) antibody isotype concentration from biological samples | Jun 29, 2023 | Pending |
Array
(
[id] => 18818797
[patent_doc_number] => 20230393137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => COMPOSITIONS AND METHODS RELATED TO DIAGNOSIS OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/325984
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18325984
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/325984 | COMPOSITIONS AND METHODS RELATED TO DIAGNOSIS OF PROSTATE CANCER | May 29, 2023 | Pending |
Array
(
[id] => 18809990
[patent_doc_number] => 20230384325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NOVEL BIOMARKER OF ACUTE CORONARY SYNDROMES
[patent_app_type] => utility
[patent_app_number] => 18/304934
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18304934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/304934 | NOVEL BIOMARKER OF ACUTE CORONARY SYNDROMES | Apr 20, 2023 | Abandoned |
Array
(
[id] => 18598425
[patent_doc_number] => 20230273224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => APPLICATION OF THBS1 PROTEIN AND THBS3 PROTEIN AS BIOMARKERS FOR DETECTING ACUTE MYOCARDIAL INFARCTION
[patent_app_type] => utility
[patent_app_number] => 18/050640
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050640 | APPLICATION OF THBS1 PROTEIN AND THBS3 PROTEIN AS BIOMARKERS FOR DETECTING ACUTE MYOCARDIAL INFARCTION | Oct 27, 2022 | Abandoned |
Array
(
[id] => 18242169
[patent_doc_number] => 20230074480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/848361
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848361 | BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF | Jun 22, 2022 | Abandoned |
Array
(
[id] => 18224023
[patent_doc_number] => 20230063017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/848365
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848365 | BIOMARKER SIGNATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS AND USES THEREOF | Jun 22, 2022 | Abandoned |
Array
(
[id] => 17884040
[patent_doc_number] => 20220299517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHOD OF EXOSOME ANALYSIS, REAGENT FOR EXOSOME ANALYSIS, AND ANALYZER FOR EXOSOME
[patent_app_type] => utility
[patent_app_number] => 17/830991
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830991 | Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome | Jun 1, 2022 | Issued |
Array
(
[id] => 17850555
[patent_doc_number] => 20220280596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => CYTOCIDAL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/740864
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740864 | CYTOCIDAL AGENT | May 9, 2022 | Abandoned |
Array
(
[id] => 17564425
[patent_doc_number] => 20220128574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHOD FOR THE DIAGNOSIS AND TREATMENT OF ESSENTIAL PRIMARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/552578
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552578 | Method for the diagnosis and treatment of essential primary hypertension | Dec 15, 2021 | Issued |
Array
(
[id] => 17898407
[patent_doc_number] => 20220308069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => MARKERS FOR ATRIAL FIBRILLATION (AF)
[patent_app_type] => utility
[patent_app_number] => 17/544359
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544359 | MARKERS FOR ATRIAL FIBRILLATION (AF) | Dec 6, 2021 | Abandoned |
Array
(
[id] => 19872223
[patent_doc_number] => 12265079
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-01
[patent_title] => Systems and methods for detecting analytes from captured single biological particles
[patent_app_type] => utility
[patent_app_number] => 17/336524
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 22799
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336524 | Systems and methods for detecting analytes from captured single biological particles | Jun 1, 2021 | Issued |
Array
(
[id] => 19872223
[patent_doc_number] => 12265079
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-01
[patent_title] => Systems and methods for detecting analytes from captured single biological particles
[patent_app_type] => utility
[patent_app_number] => 17/336524
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 22799
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336524
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336524 | Systems and methods for detecting analytes from captured single biological particles | Jun 1, 2021 | Issued |
Array
(
[id] => 16917705
[patent_doc_number] => 20210190797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Methods and reagents for diagnosis of SARS-CoV-2 infection
[patent_app_type] => utility
[patent_app_number] => 17/180616
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180616 | Methods and reagents for diagnosis of SARS-CoV-2 infection | Feb 18, 2021 | Abandoned |
Array
(
[id] => 16856105
[patent_doc_number] => 20210156850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/153134
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -113
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153134 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Jan 19, 2021 | Abandoned |
Array
(
[id] => 16870159
[patent_doc_number] => 20210163626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => ANTI-VARIANT FC-REGION ANTIBODIES AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/113684
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113684 | Anti-variant Fc-region antibodies and method of use | Dec 6, 2020 | Issued |